Patents Assigned to Idexx Corporation
  • Patent number: 7435540
    Abstract: The present invention features methods for identifying peptides that selectively bind to PrPSc or fragments thereof. The invention also features the use of such peptides in screening methods for the identification of candidate agents useful for the treatment of a prion disease.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: October 14, 2008
    Assignee: IDEXX Corporation
    Inventors: Neil Cashman, Eustache Paramithiotis, Sylvie La Boissière, Robert Lawton, Susan Francoeur, legal representative, Lisa Estey, Marc Pinard, Greg Francoeur
  • Patent number: 7407770
    Abstract: The invention provides compositions and methods for the detection and quantification of Ehrlichia chaffeensis or Ehrlichia canis, Ehrlichia chaffeensis or Ehrlichia canis antibodies, antibody fragments, and polypeptides.
    Type: Grant
    Filed: March 6, 2006
    Date of Patent: August 5, 2008
    Assignee: IDEXX Corporation
    Inventor: Thomas Patrick O'Connor, Jr.
  • Patent number: 6383765
    Abstract: An isolated envelope polypeptide of Feline Immunodeficiency Virus (FIV) that reacts specifically with a gp-130 envelope specific monoclonal antibody. Immunoassays using such isolated polypeptides are also disclosed.
    Type: Grant
    Filed: May 6, 1997
    Date of Patent: May 7, 2002
    Assignee: Idexx Corporation
    Inventors: Philip R. Andersen, Thomas P. O'Connor, Quentin J. Tonelli
  • Patent number: 5256372
    Abstract: Disclosed is a dipstick test device for detecting an analyte in a liquid sample by treating the analyte with at least one liquid reagent to form a detectable reaction product. The device includes: a) an aqueous impermeable, aqueous insoluble reaction zone, adapted to retain the detectable reaction product; and b) a control absorbent above, and in liquid-transferring relation with, the reaction zone. The control absorbent has a predetermined, limited liquid-absorbing capacity, and the dipstick is sized and configured for insertion into a vessel containing the sample, with the control absorbent oriented above the reaction zone, so that the control absorbent fills to capacity with sample and the reaction zone incubates with the sample. The device may further include an absorbent reservoir which can be moved into liquid transferring contact with the reaction zone.
    Type: Grant
    Filed: December 5, 1989
    Date of Patent: October 26, 1993
    Assignee: Idexx Corporation
    Inventors: Paul C. Brooks, Erwin F. Workman, Quentin J. Tonelli
  • Patent number: 4965187
    Abstract: A method of assaying a sample of whole blood for one member of a specific binding pair, the method involving treating the sample with salt to alter the red blood cells in the sample to decrease their ability to pass through filter media, exposing the resulting sample to a filter which retains the red blood cells but allows the passage therethrough of filtrate of the sample containing the member of the specific binding pair, and measuring the member of the filtrate.
    Type: Grant
    Filed: March 21, 1989
    Date of Patent: October 23, 1990
    Assignee: Idexx Corporation
    Inventor: Quentin J. Tonelli